Market making agreement terminated - distribution requirement met

Report this content

First day of trading without the liquidity guarantee is 1 April, 2020.

Calmark has decided to terminate the liquidity provider agreement for the company's share, which is currently delivered by Sedermera Fondkommission. Today, Calmark has a sufficient number of shareholders and thus the liquidity guarantee is no longer considered necessary. First day of trading without the liquidity guarantee is 1 April, 2020.

Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.

For more information about Calmark Sweden AB, please contact:

Anna Söderlund, CEO
Telefon: +46 70 213 25 35

Calmark Sweden AB is a medical technology company developing a point-of-care (POC) analyzis method with easier and faster sampling of medical conditions in newborns. The unique test platform, which consists of a reader and single-use products, is expected to be ready for launch in 2020 when three important POC tests are introduced. The WHO estimates that 1.5 billion children will be born worldwide by 2030. In the Western world, the introduction of POC diagnostics is resulting in huge savings and shorter healthcare chains. In less developed healthcare systems, the product helps save lives. Calmark aims to become the global leader and ultimately to offer all relevant POC tests for the first period of life, regardless of where in the world a baby is born. Read more about Calmark  


Documents & Links